Skip to main content

Panzyga

NDC 0069-1109 · Pfizer Laboratories Div Pfizer Inc

Generic nameimmune globulin intravenous (human)
Dosage formSOLUTION
RouteINTRAVENOUS
Active ingredient(s)HUMAN IMMUNOGLOBULIN G
Strength100 mg/mL
Pharmacologic classAntigen Neutralization [MoA], Human Immunoglobulin G [EPC], Immunoglobulins [CS], Passively Acquired Immunity [PE]
Marketing categoryBLA

Packages

0069-1109-02 — 1 BOTTLE, GLASS in 1 CARTON (0069-1109-02) / 25 mL in 1 BOTTLE, GLASS (0069-1109-01)

Billed under HCPCS

J1576 — Injection, immune globulin (panzyga), intravenous, non-lyophilized (e.g., liquid), 500 mg Medicare Part B payment limit (ASP + 6%): $71.35

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

0069-1011 — immune globulin intravenous (human), 0069-1061 — immunoglobulin G, 0069-1224 — immune globulin intravenous (human), 0069-1312 — immune globulin intravenous (human), 0069-1415 — immune globulin intravenous (human), 0069-1476 — immunoglobulin G, 0069-1509 — immunoglobulin G, 0069-1558 — immune globulin intravenous (human), 0069-1802 — immunoglobulin G, 0069-1960 — immunoglobulin G, 0069-1965 — immunoglobulin G, 0069-6002 — Immune Globulin, 0069-6111 — Immune Globulin, 0069-6237 — Immune Globulin, 0069-6339 — Immune Globulin, 0069-6550 — Immune Globulin, 0069-8400 — Immune Globulin, 0069-8425 — Immune Globulin, 0069-8451 — Immune Globulin, 0069-8476 — Immune Globulin, +34 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.